Clinical Trials

Title   Efficacy and Safety of Eslicarbazepine Acetate as First Add-on to Levetiracetam or Lamotrigine Monotherapy or as Later Adjunctive Treatment for Subjects with Uncontrolled Partial-onset Seizures: A Multicenter, Open-label, Non-randomized Trial
Description   A study of a drug to be used in addition with another drug to treat adults with Uncontrolled Partial-onset Seizures
IRB Number   17-492
Treatment   Epilepsy
Status   Active
Start Date   06/15/2018
Principal Name   Dean Naritoku MD
Contact Name   Tatiana Torres Herman

Email Newsletters

Connect With Us